Current and future strategies for prevention of neonatal early-onset group B streptococcus disease

Journal of Pediatric Infectious Diseases

Volumn 1, Issue 3, 2006, Pages 127-136

  Milner, Philip J ^a   Smith, Elizabeth H ^a   Spicer, Lisa ^b   Gray, James W ^a  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^b KING GEORGE HOSPITAL   (United Kingdom)

Author keywords

Diagnosis; Group B streptococcus; Neonatal infection; Prevention

Indexed keywords

EID: 85013577456     PISSN: 13057707     EISSN: 13057693     Source Type: Journal    
DOI: 10.1055/s-0035-1557080     Document Type: Article

References (94)

1. G.H. McCracken, Group B streptococci: the new challenge in neonatal infections, J Pediatr 82 (1973), 703-706.
2. R.F. Haft and D.L. Kasper, Group B streptococcus infection in mother and child, Hosp Pract (Off Ed) 26 (1991), 111-122, 125-128, 133-134.
3. H.C. Dillon Jr, S. Khare and B.M. Gray, Group Bstreptococcal carriage and disease: a 6-year prospective study, J Pediatr 110 (1987), 31-36.
4. Green-top Guideline no. 36. Prevention of early onset group B streptococcal neonatal disease, Royal College of Obstetricians & Gynaecologists, London, 2003.
5. M.A. Trijbels-Smeulders, L.A. Kollee, A.H. Adriaanse, J.L. Kimpen and L.J. Gerards, Neonatal group B streptococcal infection: incidence and strategies for prevention in Europe, Pediatr Infect Dis J 23 (2004), 172-173.
6. F. Kong, L. Ma and G.A. Gilbert, Simultaneous detection and serotype identification of Streptococcus agalactiae using multiplex PCR and reverse line blot hybridisation, J Med Microbiol 54 (2005), 1133-1138.
7. M.J. Cieslewicz, D. Chaffin, G. Glusman et al., Structural and genetic diversity of group B streptococcus capsular polysaccharides, Infect Immun 73 (2005), 3096-3103.
8. K. Grimwood, B.A. Darlow, I.A. Gosling et al., Early-onset neonatal group B streptococcal infections in New Zealand 1998-1999, J Paediatr Child Health 38 (2002), 272-277.
9. E. Persson, S. Berg, B. Trollfors et al., Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001, Clin Microbiol Infect 10 (2004), 791-796.
10. F.Y. Lin, J.D. Clemens, P.H. Azimi et al., Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection, J Infect Dis 177 (1998), 790-792.
11. A.M. Weisner, A.P. Johnson, T.L. Lamagni et al., Characterization of group B streptococci recovered from infants with invasive disease in England and Wales, Clin Infect Dis 38 (2004), 1203-1208.
12. M.E. Hickman, M.A. Rench, P. Ferrieri and C.J. Baker, Changing epidemiology of group B streptococcal colonization, Pediatrics 104 (1999), 203-209.
13. I. Le Thomas-Bories, F. Fitoussi, P. Mariani-Kurkdjian et al., Clonal relationship between US and French serotype V group B streptococcus isolates, J Clin Microbiol 39 (2001), 4526-4528.
14. J.C. de Azavedo, M. McGavin, C. Duncan, D.E. Low and A. McGeer, Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada, Antimicrob Agents Chemother 45 (2001), 3504-3508.
15. L. Decoster, J. Frans, H. Blanckaert, K. Lagrou and J. Verhaegen, Antimicrobial susceptibility of group B streptococci collected in two Belgian hospitals, Acta Clin Belg 60 (2005), 180-184.
16. M. Desjardins, K.L. Delgaty, K. Ramotor, C. Seetaram and B. Toye, Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results, J Clin Microbiol 42 (2004), 5620-5623.
17. A. Kadanali, U. Altoparlak and S. Kadanali, Maternal carriage and neonatal colonization of group B streptococcus in eastern Turkey: prevalence, risk factors and antimicrobial resistance, Int J Clin Pract 59 (2005), 437-440.
18. T.E. Schoening, J. Wagner and M. Arvand, Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany, Clin Microbiol Infect 11 (2005), 579-582.
19. J. Motlova, L. Strakova, P. Urbaskova, P. Sak and T. Sever, Vaginal & rectal carriage of Streptococcus agalactiae in the Czech Republic: incidence, serotypes distribution & susceptibility to antibiotics, Indian J Med Res 119(Suppl) (2004), 84-87.
20. A. Stylianopoulos, N. Kelly and S. Garland, Is penicillin and/or erythromycin resistance present in clinical isolates of group B streptococcus in our community? Aust N Z J Obstet Gynaecol 42 (2002), 543-544.
21. L.P. Dipersio and J.R. Dipersio, High rates of erythromycin and clindamycin resistance among OBGYN isolates of group B Streptococcus, Diagn Microbiol Infect Dis 54 (2006), 79-82.
22. U. von Both, A. Buerckstuemmer, K. Fluegge and R. Berner, Heterogeneity of genotype-phenotype correlation among macrolide-resistant Streptococcus agalactiae isolates, Antimicrob Agents Chemother 49 (2005), 3080-3082.
23. S. Schrag, R. Gorwitz, K. Fultz-Butts and A. Schuchat, Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC, MMWR Recomm Rep 51 (2002), 1-22.
24. J.J. Gonzalez and A. Andreu, Spanish group for the Study of Perinatal Infection from the Spanish Society for Clinical Microbiology and Infectious Diseases. Multicenter study of the mechanisms of resistance and clonal relationships of Streptococcus agalactiae isolates resistant to macrolides, lincosamides, and ketolides in Spain, Antimicrob Agents Chemother 49 (2005), 2525-2527.
25. C.J. Baker, D.K. Goroff, S.L. Alpert, C. Hayes and W.M. McCormack, Comparison of bacteriological methods for the isolation of group of B Streptococcus from vaginal cultures, J Clin Microbiol 4 (1976), 46-48.
26. C.S. Easmon, M.J. Hastings, J. Neill, B. Bloxham and R.P. Rivers, Is group B streptococcal screening during pregnancy justified? Br J Obstet Gynaecol 92 (1985), 197-201.
27. M.W. Platt, J.C. McLaughlin, G.J. Gilson, M.F.Wellhoner and L.J. Nims, Increased recovery of group B Streptococcus by the inclusion of rectal culturing and enrichment, Diagn Microbiol Infect Dis 21 (1985), 65-68.
28. N.C. Rauen, E.M. Wesenberg and C.P. Cartwright, Comparison of selective and nonselective enrichment broth media for the detection of vaginal and anorectal colonization with group B streptococci, Diagn Microbiol Infect Dis 51 (2005), 9-12.
29. J.S. Heelan, J. Struminsky, P. Lauro and C.J. Sung, Evaluation of a new selective enrichment broth for detection of group B streptococci in pregnant women, J Clin Microbiol 43 (2005), 896-897.
30. M. Rosa-Fraile, J. Rodriguez-Granger, E. Camacho-Munoz and A. Sampedro, Use of unmodified starches and partial removal of serum to improve Granada medium stability, J Clin Microbiol 43 (2005), 1989-1991.
31. M. de la Rosa-Fraile and E. Camacho-Munoz, Liquid Granada medium for detection of groupBstreptococci, J Clin Microbiol 43 (2005), 4303.
32. F. Rallu, P. Barriga, C. Scrivo, V. Martel-Laferriere and C. Laferriere, Sensitivities of antigen detection and PCR assays greatly increased compared to that of the standard culture method for screening for group B streptococcus carriage in pregnant women, J Clin Microbiol 44 (2006), 725-728.
33. S.M. Hansen, N. Uldbjerg, M. Kilian and U.B. Sorensen, Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants, J Clin Microbiol 42 (2004), 83-89.
34. M.J. Hastings, C.S. Easmon, J. Neill, B. Bloxham and R.P. Rivers, Group B streptococcal colonisation and the outcome of pregnancy, J Infect 12 (1986), 23-29.
35. W.E. Benitz, J.B. Gould and M.L. Druzin, Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratio by critical literature review, Pediatrics 103 (1999), e78.
36. A. Shet and P. Ferrieri, Neonatal & maternal group B streptococcal infections: a comprehensive review, Indian J Med Res 120 (2004), 141-150.
37. F.J. Picard and M.G. Bergeron, Laboratory detection of group B Streptococcus for prevention of perinatal disease, Eur J Clin Microbiol Infect Dis 23 (2004), 665-671.
38. A.K. Joshi, C.I. Chen and R.W. Turnell, Prevalence and significance of group B Streptococcus in a large obstetric population, CMAJ 137 (1987), 209-211.
39. A. Visconti, G. Orefici and A.M. Notarnicola, Colonization and infection of mothers and neonates with group B streptococci in three Italian hospitals, J Hosp Infect 6 (1985), 265-276.
40. K.M. Puopolo, L.C. Madoff and E.C. Eichenwald, Early-onset group B streptococcal disease in the era of maternal screening, Pediatrics 115 (2005), 1240-1246.
41. P.T. Heath, G. Balfour, A.M. Weisner et al., Group B streptococcal disease in UK and Irish infants younger than 90 days, Lancet 363 (2004), 292-294.
42. S.J. Schrag, E.R. Zell, R. Lynfield et al., A population-based comparison of strategies to prevent early onset group B streptococcal disease in neonates, N Engl J Med 347 (2002), 233-239.
43. H.D. Davies, M.A. Miller, S. Faro, D. Gregson, S.C. Kehl and J.A. Jordan, Multicenter study of a rapid molecular-based assay for the diagnosis of group B streptococcus colonization in pregnant women, Clin Infect Dis 39 (2004), 1129-1135.
44. A.J. Daley and D. Isaacs, Australasian Study Group for Neonatal Infections. Ten-year study on the effect of intrapartum antibiotic prophylaxis on early onset group B streptococcal and Escherichia coli neonatal sepsis in Australasia, Pediatr Infect Dis J 23 (2004), 630-634.
45. J. Andersen, R. Christensen and J. Hertel, Clinical features and epidemiology of septicaemia and meningitis in neonates due to Streptococcus agalactiae in Copenhagen County, Denmark:a 10 year survey from 1992 to 2001, Acta Paediatr 93 (2004), 1334-1339.
46. L. Ragunathan, M. Ramsay, R. Borrow, M. Guiver, S. Gray and E.B. Kaczmarski, Clinical features, laboratory findings and management of meningococcal meningitis in England and Wales: report of a 1997 survey. Meningococcal meningitis: 1997 survey report, J Infect 40 (2000), 74-79.
47. S. Luck, M. Torny, K. d’Agapeyeff et al., Estimated earlyonset group B streptococcal neonatal disease, Lancet 361 (2003), 1953-1954.
48. J.A. Regan, S. Chao and L.S. James, Premature rupture of membranes, preterm delivery, and group B streptococcal colonization of mothers, Am J Obstet Gynecol 141 (1981), 184-186.
49. M.A. Klebanoff, J.A. Regan, A.V. Rao et al., Outcome of the Vaginal Infections and Prematurity Study: results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci, Am J Obstet Gynecol 172 (1995), 1540-1545.
50. H. McDonald, R. Vigneswaran and J.A. O’Loughlin, Group B streptococcal colonization and preterm labour, Aust NZ J Obstet Gynaecol 29 (1989), 291-293.
51. R. Matorras, A. Garcia Perea, F. Omenaca, J.A. Usandizaga, A. Nieto and R. Herruzo, Group B streptococcus and premature rupture of membranes and preterm delivery, Gynecol Obstet Invest 27 (1989), 14-18.
52. S.M. Garland, N. Kelly and A.M. Ugoni, Is antenatal group B streptococcal carriage a predictor of adverse obstetric outcome? Infect Dis Obstet Gynecol 8 (2000), 138-142.
53. R. Romero, M. Mazor, E. Oyarzun, M. Sirtori, Y.K. Wu and J.C. Hobbins, Is there an association between colonization with group B Streptococcus and prematurity? J Reprod Med 34 (1989), 797-801.
54. P. Dermer, C. Lee, J. Eggert and B. Few, A history of neonatal group B streptococcus with its related morbidity and mortality rates in the United States, J Pediatr Nurs 19 (2004), 357-363.
55. S. Oddie and N.D. Embleton, Risk factors for early onset neonatal group B streptococcal sepsis: case-control study, BMJ 325 (2002), 308.
56. A.H. Adriaanse, I. Lagendijk, H.L. Muytjens, J.G. Nijhuis and L.A. Kollee, Neonatal early onset group B streptococcal infection. A nine-year retrospective study in a tertiary care hospital, J Perinat Med 24 (1996), 531-538.
57. R.S. Gibbs, S. Schrag and A. Schuchat, Perinatal infections due to group B streptococci, Obstet Gynecol 104 (2004), 1062-1076.
58. C.E. Adair, L. Kowalsky, H. Quon et al., Risk factors for earlyonset group B streptococcal disease in neonates: a populationbased case-control study, CAMJ 169 (2003), 198-203.
59. O. Lyytikainen, J.P. Nuorti, E. Halmesmaki et al., Invasive group B streptococcal infections in Finland: a populationbased study, Emerg Infect Dis 9 (2003), 469-473.
60. R. Spaetgens, K. deBella, D. Ma, S. Robertson, M. Mucenski and H.D. Davies, Perinatal antibiotic usage and changes in colonization and resistance rates of group B streptococcus and other pathogens, Obstet Gynecol 100 (2002), 525-533.
61. F. Smaill, Intrapartum antibiotics for group B streptococcal colonization, Cochrane Database Syst Rev 2 (2000), CD000115.
62. M. May, A.J. Daley, S. Donath and D. Isaacs, Australasian Study Group for Neonatal Infections. Early onset neonatal meningitis in Australia and New Zealand, 1992-2002, Arch Dis Child Fetal Neonatal Ed 90 (2005), F324-F327.
63. S.L. Lukacs, K.C. Schoendorf and A. Schuchat, Trends in sepsis-related neonatal mortality in the United States, 1985-1998, Pediatr Infect Dis J 23 (2004), 599-603.
64. K. Beardsall, M.H. Thompson and R.J. Mulla, Neonatal group B streptococcal infection in South Bedfordshire, 1993-1998, Arch Dis Child Fetal Neonatal Ed 82 (2000), F205-F207.
65. H.D. Davies, C.E. Adair, A. Schuchat, D.E. Low, R.S. Sauve and A. McGeer, Alberta Group B Streptococcal Network and the Toronto Invasive Bacterial Diseases Network. Physicians’ prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions, CMAJ 164 (2001), 479-485.
66. L. Riley, K. Appollon, S. Haider et al., "Real World" compliance with strategies to prevent early-onset group B streptococcal disease, J Perinatol 23 (2003), 272-277.
67. G.L. Gilbert, M.C. Hewitt, C.M. Turner and S.R. Leeder, Compliance with protocols for prevention of neonatal group B streptococcal sepsis: practicalities and limitations, Infect Dis Obstet Gynecol 11 (2003), 1-9.
68. M.E. Weiss and N.F. Adkinson, Immediate hypersensitivity reactions to penicillin and related antibiotics, Clin Allergy 18 (1988), 515-540.
69. K.T. Chen, K.M. Puopolo, E.C. Eichenwald, A.B. Onderdonk and E. Lieberman, No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B streptococcus in the era of intrapartum antibiotic prophylaxis, Am J Obstet Gynecol 192 (2005), 1167-1171.
70. A.K.Wierzbowski, D.J. Hoban, T. Hisanaga, M. Decorby and G.G. Zhanel, The use of macrolides in treatment of upper respiratory tract infections, Curr Infect Dis Rep 7 (2005), 175-184.
71. S.L. Kenyon, D.J. Taylor and W. Tarnow-Mordi, ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group, Lancet 357 (2001), 979-988.
72. K. Mayor-Lynn, V.H. Gonzalez-Quintero, M.J. O’Sullivan, A.I. Hartstein, S. Roger and M. Tamayo, Comparison of earlyonset neonatal sepsis caused by Escherichia coli and group B streptococcus, Am J Obstet Gynecol 192 (2005), 1437-1439.
73. F. Jaureguy, M. Carton, P. Panel, P. Foucaud, M.J. Butel and F. Doucet-Populaire, Effects of intrapartum penicillin prophylaxis on intestinal bacterial colonization in infants, J Clin Microbiol 42 (2004), 5184-5188.
74. M.G. Bergeron, D. Ke, C. Menard et al., Rapid detection of group B streptococci in pregnant women at delivery, N Engl J Med 343 (2000), 175-179.
75. T.M. Nguyen, D.W. Gauthier, T.D. Myles, B.S. Nuwayhid, M.A. Viana and P.C. Schreckenberger, Detection of group B streptococcus: comparison of an optical immunoassay with direct plating and broth-enhanced culture methods, J Matern Fetal Med 7 (1998), 172-176.
76. R. Samadi, A. Stek and J.S. Greenspoon, Evaluation of a rapid optical immunoassay-based test for group B streptococcus colonization in intrapartum patients, J Matern Fetal Med 10 (2001), 203-208.
77. J. Thinkhamrop, S. Limpongsanurak, M. Festin et al., Infections in international pregnancy study: performance of the optical immunoassay for the detection of group B streptococcus, J Clin Microbiol 41 (2003), 5288-5290.
78. P. Milner, E. Smith and J. Gray, Is PCR feasible as a point of care test? Presented at the Federation of Infection Societies Scientific Meeting 2005, Cardiff, UK, 7-9 November 2005.
79. http://www.hta.nhsweb.nhs.uk/ProjectData.
80. C.J. Baker and M.S. Edwards, Group B streptococcal conjugate vaccines, Arch Dis Child 88 (2003), 375-378.
81. G.L. Gilbert, Vaccines for other neonatal infections: are group B streptococcal infections vaccine-preventable? Expert Rev Vaccines 3 (2004), 371-374.
82. P.T. Heath and R.G. Feldman, Vaccination against group B streptococcus, Expert Rev Vaccines 4 (2005), 207-218.
83. L.C. Paoletti and L.C. Madoff, Vaccines to prevent neonatal GBS infection, Semin Neonatol 7 (2002), 315-323.
84. G. Fischer, R.E. Horton and R. Edelman, From the National Institute of Allergy and Infectious Diseases. Summary of the National Institutes of Health workshop on group B streptococcal infection, J Infect Dis 148 (1983), 163-166.
85. A. Sinha, T.A. Lieu, L.C. Paoletti, M.C. Weinstein and R. Platt, The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis, Vaccine 23 (2005), 3187-3195.
86. F.Y. Lin, L.E. Weisman, P.H. Azimi et al., Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen, J Infect Dis 190 (2004), 928-934.
87. F.Y. Lin, J.B. 3rd Philips, P.H. Azimi et al., Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study, J Infect Dis 184 (2001), 1022-1028.
88. K. Hordnes, T. Tynning, A.I. Kvam et al., Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R, Scand J Immunol 47 (1998), 179-188.
89. D. Maione, I. Margarit, C.D. Rinaudo et al., Identification of a universal Group B streptococcus vaccine by multiple genome screen, Science 309 (2005), 148-150.
90. R.L. Brent, Risks and benefits of immunizing pregnant women: The risk of doing nothing, Reprod Toxicol 21 (2006), 383-389.
91. D.M. Salisbury and N.T. Begg, eds, Immunisation Against Infectious Disease, HMSO, London, 1996.
92. R.I. Shahdadpuri, A.J. Nicholson, D. Bedford and D. O’Flanagan, Pertussis-going, going, but not gone: thirteen year trends in the incidence of pertussis in the Republic of Ireland and North Eastern Health Board, Ir Med J 97 (2004), 44-46.
93. J.A. Wright and C. Polack, Understanding variation in measles-mumps-rubella immunization coverage-a population-based study, Eur J Public Health 16 (2006), 137-142.
94. P. Darbyshire, C. Collins, H.M. McDonald and J.E. Hiller, Taking antenatal group B Streptococcus seriously: women’s experiences of screening and perceptions of risk, Birth 30 (2003), 116-123.